Literature DB >> 32639942

Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.

Julien Favresse1,2, Christine Eucher1, Marc Elsen1, Kim Laffineur1, Jean-Michel Dogné2, Jonathan Douxfils2,3.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; kinetics; serology; symptom onset

Mesh:

Substances:

Year:  2020        PMID: 32639942     DOI: 10.1515/cclm-2020-0962

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  5 in total

1.  Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.

Authors:  Hélène Haguet; Jonathan Douxfils; Christine Eucher; Marc Elsen; Julie Cadrobbi; Marie Tré-Hardy; Jean-Michel Dogné; Julien Favresse
Journal:  J Med Virol       Date:  2021-03-01       Impact factor: 20.693

2.  Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays.

Authors:  C S Lau; M S Wong; S P Hoo; P Y Heng; S K Phua; T C Aw
Journal:  Pract Lab Med       Date:  2021-10-13

3.  High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.

Authors:  Antoine Mairesse; Julien Favresse; Christine Eucher; Marc Elsen; Marie Tré-Hardy; Caroline Haventith; Damien Gruson; Jean-Michel Dogné; Jonathan Douxfils; Paul Göbbels
Journal:  Clin Biochem       Date:  2020-08-25       Impact factor: 3.281

4.  Delayed SARS-COV-2 leukoencephalopathy without Severe Hypoxia.

Authors:  Arooshi Kumar; Anlys Olivera; Nancy Mueller; Jonathan Howard; Ariane Lewis
Journal:  J Neurol Sci       Date:  2020-09-18       Impact factor: 3.181

5.  Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.

Authors:  Julien Favresse; Julie Cadrobbi; Christine Eucher; Marc Elsen; Kim Laffineur; Jean-Michel Dogné; Jonathan Douxfils
Journal:  J Med Virol       Date:  2020-12-01       Impact factor: 20.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.